Global Wearable Injectors Market

Global Wearable Injectors Market Size, Share, Growth Analysis, By Type(On-Body, Off-Body), By Therapy(Diabetes, Cardiovascular disease) - Industry Forecast 2024-2031


Report ID: SQSG35B2020 | Region: Global | Published Date: February, 2024
Pages: 263 | Tables: 63 | Figures: 76

Global Wearable Injectors Market Dynamics

Wearable Injectors Market Driver

  • The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.
  • Since biologics and mAbs must be administered parenterally, greater emphasis on their use to cure conditions like cancer, rheumatoid arthritis, and heart disease would open up significant development opportunities for wearable injectors that deliver drugs subcutaneously, intravenously, or intramuscularly. In past years, a sizable number of biologics were also being developed, and the amount of biologic pharmaceuticals under development is still growing rapidly. 

Wearable Injectors Market Restraint

  • Due to the costs and hassles associated with conservative settings, people have been compelled to switch to more affordable choices, leading to favor for such injectors. These injectors offer benefits like ease of administration, pain relief, and decreased untimeliness when connected to syringes, all of which contribute to market growth.
  • Wearable injectors are not widely available in many countries due to unfavorable reimbursement policies. Several developing countries do not pay for wearable injectors. Wearable injector accessibility and adoption are directly impacted by the lack of reimbursement.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Wearable Injectors Market size was valued at USD 6.66 billion in 2019 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).

Many businesses in the market for producing wearable injectors are now concentrating on expanding their production capacities through mergers and acquisitions. For the purpose of acquiring new features or gaining entry into new markets, large primary manufacturers are creating joint ventures or purchasing small or midsized businesses. Additionally, businesses are investing in the creation of enhanced products. They are also concentrating on keeping their prices competitive. For instance, in April 2021, the Medtronic Extended infusion set is the first and only infusion set that may be worn for up to 7 days, according to an announcement made by Medtronic plc. 'Ypsomed', 'Amgen', 'Subcuject (Denmark)', 'Becton, Dickinson and Company (BD)', 'Bespak Europe Ltd.', 'CeQur SA', 'Debiotech SA', 'Enable Injections', 'Insulet Corporation', 'Medtronic plc', 'Mylan N.V.', 'Nemera Development S.A.', 'Omron Corporation', 'Pfizer Inc.', 'Roche Holding AG', 'Sensile Medical AG', 'SteadyMed Therapeutics, Inc.', 'Tandem Diabetes Care, Inc.', 'United Therapeutics Corporation', 'West Pharmaceutical Services, Inc.', 'Zosano Pharma Corporation'

The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.

The rising popularity of at-home, self-administered injectors for treating illnesses with little chance of dosage error and needle stick injuries. Other growth-promoting aspects include a number of product developments, such as the incorporation of Bluetooth, wireless communication, and passive warning systems with injectors. These innovations allow for comfortable patient monitoring via a mobile application and offer prompt medication reminders.

In terms of revenue, North America held the largest wearable injector market globally in 2021, and it is expected that it will continue to do so during the projection timeframe. This is explained by the spike in the number of people with various medical conditions. Furthermore, the requirement for the wearable injector market is being fueled by the introduction of numerous novel medications that may successfully cure chronic diseases. Additionally, the growing acceptance of tailored pharmaceuticals may have a favorable effect on the market in the years to come.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Wearable Injectors Market

Product ID: SQSG35B2020

$5,300
BUY NOW GET FREE SAMPLE